Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 4:39 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2113–2136 of 6,925 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control, small Clear all

Conditions: Leukemia, Lymphoma, Oral Complications
Interventions: filgrastim, palifermin, cyclophosphamide, etoposide, ifosfamide, peripheral blood stem cell transplantation, quality-of-life assessment, radiation therapy; Biological · Drug · Procedure + 1 more
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2009
U.S. locations: 1
States / cities: New York, New York

Conditions: Carcinoma, Non- Small Cell Lung
Interventions: Durvalumab, Placebo; Drug · Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 10
States / cities: Long Beach, California • Los Angeles, California • Daytona Beach, Florida + 7 more

Conditions: Fatigue, Chronic Low Back Pain
Interventions: Relaxation acupressure, Stimulating acupressure; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Follicular Lymphoma, Recurrent Lymphoplasmacytic Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Follicular Lymphoma, Refractory Lymphoplasmacytic Lymphoma, Refractory Mantle Cell Lymphoma, Refractory Transformed Non-Hodgkin Lymphoma, Recurrent Transformed B-Cell Non-Hodgkin Lymphoma, Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Marginal Zone Lymphoma, Refractory Transformed B-Cell Non-Hodgkin Lymphoma, Refractory Transformed Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Small Lymphocytic Lymphoma, Recurrent Central Nervous System Lymphoma, Refractory Central Nervous System Lymphoma
Interventions: Chimeric Antigen Receptor T-Cell Therapy, Cyclophosphamide, Laboratory Biomarker Analysis, Leukapheresis, Fludarabine Phosphate; Biological · Drug · Other + 1 more
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2039
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Sensorineural Hearing Loss
Interventions: Hearing Aid fitting; Device
Lead sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.; Other
Eligibility: 18 Years to 100 Years
Enrollment: 186 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Brighton, Massachusetts

Conditions: Wrist Injuries, PRP
Interventions: Platelet-rich plasma (PRP); Procedure
Lead sponsor: Edna Rath; Federal
Eligibility: Not listed
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Cancer, Solid Tumor
Interventions: IMC-1121B, Moxifloxacin, Diphenhydramine; Biological · Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 7
States / cities: Atlanta, Georgia • Metairie, Louisiana • Ann Arbor, Michigan + 4 more

Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions: Music-Based Binaural Beats Stimulation, Music Listening Without Binaural Beats; Behavioral
Lead sponsor: California State University, San Bernardino; Other
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Bernardino, California

Conditions: Postoperative Pain, Narcotic Use, Cryotherapy Effect
Interventions: Opioid-sparing multimodal pain management, Usual care; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: DERMATOMYOSITIS OR POLYMYOSITIS
Interventions: MEDI-545, Placebo; Biological · Other
Lead sponsor: MedImmune LLC; Industry
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 14
States / cities: Scottsdale, Arizona • Stanford, California • Whittier, California + 11 more

Conditions: Indolent Non-Hodgkin's Lymphomas
Interventions: Placebo, Rituximab, Idelalisib; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 32
States / cities: Huntsville, Alabama • Chandler, Arizona • Duarte, California + 28 more

Conditions: Participants Undergoing Anthracycline Chemotherapy
Interventions: autoRIC®; Device
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 11 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Heart Failure
Interventions: Cardiac rehab; Other
Lead sponsor: Sanford Health; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Emotional Dysregulation
Interventions: Project WAVE (Wise Awareness of Visiting Emotions), Emotionally Neutral Writing Control; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 29 Years
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Mild Cognitive Impairment, Dementia, BPSD, BPSD (Behavioral and Psychological Symptoms of Dementia), Reminiscence Therapy
Interventions: Smart Virtual Reminiscence Therapy, Music Therapy; Device · Other
Lead sponsor: Indiana University; Other
Eligibility: 65 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Dentine Hypersensitivity
Interventions: Stannous fluoride, Sodium monofluorophosphate; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 119 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Fort Wayne, Indiana

Conditions: Computerized Anxiety Sensitivity Treatment, Health Education Treatment
Interventions: CAST, HET; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years and older
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Preterm Birth, Pain
Interventions: Music Based Intervention, Sham Treatment; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 28 Weeks to 32 Weeks
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Congenital Hyperinsulinism
Interventions: Exendin-(9-39), Vehicle; Drug · Other
Lead sponsor: Diva De Leon; Other
Eligibility: 7 Years to 60 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Smoking Cessation, Cigarette Smoking, Smoking (Tobacco) Addiction
Interventions: Nicotine Film; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 55 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: COVID-19
Interventions: Full Intervention, Enhanced Usual Care; Behavioral · Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 988 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Atlanta, Georgia • Seattle, Washington

Conditions: Axial Spondyloarthritis
Interventions: RENEW; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Obesity, Activity, Motor, Diet, Healthy, Sedentary Behavior
Interventions: Healthy Juntos; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 12 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Psychopathology
Interventions: Mom Power, Mom Power Informational Mailing; Behavioral
Lead sponsor: Tulane University; Other
Eligibility: 3 Years and older
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New Orleans, Louisiana

Search by objective public record fields.

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

Acupressure for Fatigue and Low Back Pain

A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Investigation of Anatomical Correlates of Speech Discrimination

A Prospective Randomized Double Blinded Controlled Trial of Non-Operative Management of TFCC Injuries

Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes

Binaural Beats Stimulation for Adults With Attention-Deficit/Hyperactivity Disorder

Novel Multimodal Pain Control Protocol for Minimally Invasive Gynecologic Surgery

A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

Remote Ischemic Conditioning in Oncology

Study to Evaluate the Effectiveness of Cardiac Rehabilitation (Rehab) for Acute Decompensated Heart Failure Patients on 6 Minute Walk Test and Quality of Life

A Single-Session Intervention Fostering Emotional Nonreactivity

Multi-modal Large Language Model-Empowered Talk Therapy for Older Adults With ADRD

Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity

Evaluation of the Feasibility and Efficacy of Computerized Anxiety Treatment in a Group Setting

Effects of Music Based Intervention (MBI) on Pain Response and Neurodevelopment in Preterm Infants

Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism

Effects of Random Nicotine Delivery on Smoking Cessation

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities

RENEW Intervention for Axial Spondyloarthritis

Healthy Juntos Pilot Study

Virtual Mom Power With High-Adversity Mothers and Children (MPHAMC)